STAT+: Cancer drug indications remain on labels even after trials fail to confirm their benefits
One-third of the uses for cancer drugs granted speedy approvals remained on product labeling even…
Author: STAT
Opinion: STAT+: Combating the burnout bottleneck among clinical research workers
Health care professionals of all stripes were battling burnout and mental illness before the pandemic…
A vaccine veteran steps away from the NIH, looking out toward the world
In early January 2020, most of the world hadn’t yet awakened to the fact that…
STAT+: After a decade at Facebook and Google, a tech exec tries his hand at drug development
After building Facebook’s search bar into a pivotal part of its platform, Tom Stocky is…
Opinion: How a ‘fatally, tragically flawed’ paradigm has derailed the science of obesity
I’ve been a science reporter for 40 years. I’ve wanted to assume that the experts…
STAT+: Scientist Aubrey de Grey made inappropriate sexual comments to two female entrepreneurs, independent investigation finds
Aubrey de Grey, the anti-aging research pioneer who was removed last month as chief scientific…
STAT+: Biogen trials for Alzheimer’s drug excluded much of the targeted patient pool, study finds
A new analysis finds that the clinical trials conducted by Biogen (BIIB) for its controversial…
Biden administration releases $25 billion in Covid relief for providers after months of delay
WASHINGTON — The Biden administration on Friday announced plans to release more than $25 billion to…
.jpg)
STAT+: Pharmalittle: Endo pays $50 million to settle opioid case; Senate mulls pegging drug prices to VA discounts
And so, another working week will soon draw to a close. Not a moment too…
Opinion: Covid-19 trauma complicates the 9/11 ‘anniversary effect’
Trauma caused by violence or tragic events can have a huge impact on individuals’ lives….
Opinion: Outdated rule increases Medicare’s costs for generic drugs by $26 billion a year
Public outcry about the shockingly high cost of brand-name drugs and a demand for new…
Any qualms about an extra Covid vaccine dose? STAT readers respond
Covid-19 vaccine boosters continue to stir controversy as most of the world seeks a first…
Listen: Verily’s moment of truth, Aduhelm’s rocky rollout, & the problem with Covid testing
Are we ever getting that Tricorder? Why’s it so hard to find Covid-19 tests? And…
STAT+: The future of Apellis Pharma’s eye disease treatment is clouded by divergent study results
Apellis Pharmaceuticals has a good news-bad news problem involving its experimental treatment for geographic atrophy…
FDA misses deadline for deciding which e-cigarette products should be removed from the market
WASHINGTON — The Food and Drug Administration announced Thursday that it has failed to meet…
STAT+: For the first time, the FDA warns a trial investigator for failing to report study results
In a little noticed warning, the Food and Drug Administration threatened to fine the principal…
STAT+: Senate considers pegging Medicare drug prices to deeply discounted Veterans Affairs rates
WASHINGTON — Senate lawmakers are actively considering pegging the prices Medicare pays for drugs to…
An Alphabet spinout faces the ultimate test
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
Biogen admits Aduhelm launch ‘slower than we anticipated’
Biogen CEO Michel Vounatsos admitted Thursday that the launch of Aduhelm, the company’s intensely scrutinized…
New Biden plan to lower drug prices drawn from familiar Democratic playbook
WASHINGTON — The Biden administration on Thursday unveiled a long-awaited plan to lower prescription drug…
STAT+: Pharmalittle: Biden drug-pricing plan backs Medicare negotiations; Moderna tests combined Covid-19 booster and flu shot
Good morning, everyone, and nice to see you again. We have finally returned from an…
FDA’s rejection of Humanigen drug highlights problems in developing Covid-19 treatments
The Food and Drug Administration has declined to grant emergency use authorization to lenzilumab, an…
.jpg)
STAT+: Early data suggest monthly hemophilia drug could contend with gene therapy
Centessa, a biotech company that raised more than $300 million in an IPO earlier this…
Opinion: STAT+: Digital clinical trials can personalize patient engagement, accelerate therapy development
Biopharmaceutical companies were conducting more than 9,000 clinical trials in the U.S. in March 2020…
A startup delivers mental health care to those missed by the unicorns
The explosion of investor interest in behavioral health startups has minted an expanding list of…
How the Delta variant’s remarkable ability to replicate threw new twists into the Covid-19 pandemic
One of the key reasons the Delta variant has ignited new surges of Covid-19 infections across…
Medical cannabis unlikely to benefit most chronic pain patients, international researchers say
Medical cannabis might be a helpful therapy for some people who have chronic pain, but…
Pandemic lockdown tied to worse outcomes in metastatic colorectal cancer, French study says
One of the most pressing questions during the coronavirus pandemic has been its impact on…
STAT+: Pharmalittle: Sanofi will acquire Kadmon Pharma for $1.9 billion; Theranos founder Elizabeth Holmes goes on trial
Good morning. Happy Wednesday. This is Kate Sheridan, filling in for Ed Silverman this morning…
Moderna turns to biotech startup to ramp up Covid vaccine manufacturing
Moderna will turn to a biotech startup, National Resilience, to manufacture additional doses of its…
Sanofi acquires Kadmon for $1.9 billion, adding transplant medicine drug
French drug maker Sanofi said Wednesday that it will acquire Kadmon Pharmaceuticals for $1.9 billion,…
Opinion: Listen: A scientist-parent on heading back-to-school with Delta
Alicia Zhou was worried about sending her son, Davi, to in-person first grade this year,…
STAT+: In another sign of RNA’s growing popularity, the cancer startup Replicate is relaunching
A California startup is putting a new spin on a now-familiar idea: using RNA as…
In the hunt for novel antibiotics, will new technology overtake underwater exploration?
LAKE SUPERIOR — Choppy, windswept waves slap at the hull as our boat nears the…
STAT+: Inside Verily’s make-or-break push to turn its most promising ideas into profits
It’s a make or break moment for Verily, as the sprawling Google offshoot rapidly accelerates…
STAT+: FDA dings Kaleido Biosciences for testing a microbiome drug without proper paperwork
The Food and Drug Administration is warning Lexington, Mass.-based Kaleido Biosciences that it shouldn’t have…
Congress is ready to dig into drug prices
You’re reading the web edition of D.C. Diagnosis, STAT’s weekly newsletter about the politics and…
STAT+: STAT+ Conversation: Which biotech venture capitalist funds performed best during the pandemic?
Editor’s note: A livestream of the conversation will be embedded below at 2 p.m. ET….
The telehealth revolution is still in its nascent stages
You’re reading the web edition of STAT Health Tech, our guide to how tech is…
STAT+: Pharmalittle: CEPI warns of hurdle to new Covid-19 vaccines; reading tea leaves on booster side effects
G’morning to ya! Nicholas St. Fleur here to fill in for Ed following this Labor…
CEPI warns of major hurdle to developing new Covid-19 vaccines and studying best booster approaches
The world still needs more — and better — Covid-19 vaccines. But a major hurdle stands…
Opinion: To lower drug costs, define ‘cost’ to mean net cost after rebates
In what could be a turning point in the prescription drug debate, President Biden has…
STAT+: The FDA has just 3 days to decide how to regulate 6.5 million e-cigarette products. But what if it blows past the deadline?
WASHINGTON — The Food and Drug Administration has just three days until it must finally…
How the risk of side effects could change with Covid-19 vaccine boosters
Additional doses of Covid-19 vaccines are likely rolling out in the United States later this…
Never-smokers’ lung cancers are genetically different from smokers’ tumors, study shows
Researchers have identified unique genetic signatures of lung cancer in people who never smoked cigarettes,…
Visualizing how fast the pandemic is getting better or worse, state by state
Well over a year into the Covid-19 pandemic, visualizations of case data have become ubiquitous….
STAT+: Democrats want to let Medicare negotiate drug prices. Has pharma found a way to lessen the blow, already?
WASHINGTON — As Democrats design a way to use the government’s leverage to lower drug…
The White House wants $65 billion for an Apollo-style pandemic preparedness program
WASHINGTON — The Biden administration on Friday unveiled a sweeping new biosecurity plan, outlining a…
STAT+: Pharmalittle: Lawmakers ramp up probe of FDA approval of Biogen drug; EU to return J&J Covid-19 shots to Africa
And so, another working week will soon draw to a close. Not a moment too…
Opinion: ‘Reentry’ after cancer treatment offers lessons for emerging from the pandemic
An interesting and important period in the life of cancer survivors begins when major treatments,…